MetaADEDB 2.0 @ LMMD
amitriptyline, chlordiazepoxide drug combination
(KFYRPLNVJVHZGT-UHFFFAOYSA-N)
Structure
SMILES
CN(CCC=C1c2ccccc2CCc2c1cccc2)C.Cl
Molecular Formula:
C20H24ClN
Molecular Weight:
313.864
Log P:
4.9706
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
3.24
CAS Number(s):
549-18-8
Synonym(s)
1.
amitriptyline, chlordiazepoxide drug combination
2.
Limbitrol
3.
Limbritol
4.
amitriptyline - chlordiazepoxide
5.
amitriptyline hydrochloride, chlordiazepoxide drug combination
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Completed SuicideFAERS: 30US FAERS
2Drug ineffectiveFAERS: 28
Canada Vigilance: 5
Canada Vigilance
US FAERS
3TremorFAERS: 20US FAERS
4HeadacheFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
5OverdoseFAERS: 17US FAERS
6DizzinessFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
7SomnolenceFAERS: 13
Canada Vigilance: 7
Canada Vigilance
US FAERS
8Drug ineffective for unapproved indicationFAERS: 11US FAERS
9Memory impairmentFAERS: 11US FAERS
10FatigueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Feeling abnormalFAERS: 10US FAERS
12Drug dispensing errorFAERS: 9US FAERS
13DysgeusiaFAERS: 9US FAERS
14TachycardiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
15DisorientationFAERS: 8US FAERS
16HypersensitivityFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Medication ErrorFAERS: 8US FAERS
18NauseaFAERS: 8US FAERS
19TinnitusFAERS: 8US FAERS
20Toxicity to various agentsFAERS: 8US FAERS
21AgitationFAERS: 7US FAERS
22AnxietyFAERS: 7
Canada Vigilance: 3
Canada Vigilance
US FAERS
23Cardiac ArrestFAERS: 7US FAERS
24DysarthriaFAERS: 7US FAERS
25HypotensionFAERS: 7US FAERS
26Suicide attemptFAERS: 7US FAERS
27VomitingFAERS: 7US FAERS
28Wrong technique in product usage processFAERS: 7US FAERS
29Abdominal PainFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
30CryingFAERS: 6US FAERS
31Depressed Level of ConsciousnessFAERS: 6US FAERS
32Electrocardiogram abnormalFAERS: 6US FAERS
33Abdominal discomfortFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
34AmnesiaFAERS: 5US FAERS
35Drug DependenceFAERS: 5US FAERS
36Incorrect dose administeredFAERS: 5US FAERS
37Mental status changesFAERS: 5US FAERS
38Status EpilepticusFAERS: 5US FAERS
39AbasiaFAERS: 4US FAERS
40AngerFAERS: 4US FAERS
41Back PainFAERS: 4US FAERS
42Blood glucose abnormalFAERS: 4US FAERS
43Chest PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Drug withdrawal syndromeFAERS: 4US FAERS
45Intentional product misuseFAERS: 4US FAERS
46LethargyFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
47MalaiseFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Metabolic acidosisFAERS: 4US FAERS
49Muscle RigidityFAERS: 4US FAERS
50Muscle tightnessFAERS: 4US FAERS
51MydriasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
52NephrolithiasisFAERS: 4US FAERS
53PainFAERS: 4US FAERS
54PalpitationsFAERS: 4US FAERS
55Pharmaceutical product complaintFAERS: 4US FAERS
56Product quality issueFAERS: 4US FAERS
57Product use issueFAERS: 4US FAERS
58Reaction to drug excipientsFAERS: 4US FAERS
59Throat irritationFAERS: 4US FAERS
60Urinary RetentionFAERS: 4US FAERS
61Ventricular FibrillationFAERS: 4US FAERS
62Accidental overdoseFAERS: 3US FAERS
63Activities of daily living impairedFAERS: 3US FAERS
64Adverse eventFAERS: 3US FAERS
65AlopeciaFAERS: 3US FAERS
66Altered state of consciousnessFAERS: 3US FAERS
67AstheniaFAERS: 3US FAERS
68Burning sensationFAERS: 3US FAERS
69ChillsFAERS: 3US FAERS
70CholecystitisFAERS: 3US FAERS
71ConstipationFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
72Depressed moodFAERS: 3US FAERS
73Drug abuserFAERS: 3US FAERS
74Drug screen positiveFAERS: 3US FAERS
75Drug toxicityFAERS: 3US FAERS
76DysphoniaFAERS: 3US FAERS
77FlatulenceFAERS: 3US FAERS
78GastroenteritisFAERS: 3US FAERS
79HypersomniaFAERS: 3US FAERS
80MenorrhagiaFAERS: 3US FAERS
81NervousnessFAERS: 3US FAERS
82ParanoiaFAERS: 3US FAERS
83Poor quality sleepFAERS: 3US FAERS
84Product substitution issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
85PruritusFAERS: 3US FAERS
86ShockFAERS: 3US FAERS
87SyncopeFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Tooth LossFAERS: 3US FAERS
89Unevaluable eventFAERS: 3US FAERS
90Unresponsive to stimuliFAERS: 3US FAERS
91AcneFAERS: 2US FAERS
92Alanine Aminotransferase IncreasedFAERS: 2US FAERS
93Anaphylactic shockFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
94Anticholinergic SyndromeFAERS: 2US FAERS
95Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
96Blood electrolytes abnormalFAERS: 2US FAERS
97Blood glucose increasedFAERS: 2US FAERS
98Blood sodium decreasedFAERS: 2US FAERS
99BradycardiaFAERS: 2US FAERS
100Chest discomfortFAERS: 2US FAERS
101ChromaturiaFAERS: 2US FAERS
102Cold sweatFAERS: 2US FAERS
103Drug screen negativeFAERS: 2US FAERS
104DyspepsiaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Euphoric moodFAERS: 2US FAERS
106Expired product administeredFAERS: 2US FAERS
107False positive investigation resultFAERS: 2US FAERS
108Feeling jitteryFAERS: 2US FAERS
109InflammationFAERS: 2US FAERS
110Intentional misuseFAERS: 2US FAERS
111Intercepted drug dispensing errorFAERS: 2US FAERS
112Mood swingsFAERS: 2US FAERS
113MyalgiaFAERS: 2US FAERS
114Oropharyngeal painFAERS: 2US FAERS
115Peripheral swellingFAERS: 2US FAERS
116Pharmaceutical product counterfeitFAERS: 2US FAERS
117PhotophobiaFAERS: 2US FAERS
118PoisoningFAERS: 2US FAERS
119Product taste abnormalFAERS: 2US FAERS
120Product use in unapproved indicationFAERS: 2US FAERS
121Pulmonary EmbolismFAERS: 2US FAERS
122Respiratory arrestFAERS: 2US FAERS
123RestlessnessFAERS: 2US FAERS
124Sinus TachycardiaFAERS: 2US FAERS
125SwellingFAERS: 2US FAERS
126Tardive DyskinesiaFAERS: 2US FAERS
127Transaminases increasedFAERS: 2US FAERS
128White blood cell count decreasedFAERS: 2US FAERS
129Abdominal symptomFAERS: 1US FAERS
130Accidental drug intake by childFAERS: 1US FAERS
131Accidental exposure to productFAERS: 1US FAERS
132Acute Lung InjuryFAERS: 1US FAERS
133Alcohol poisoningFAERS: 1US FAERS
134Antidepressant drug level above therapeuticFAERS: 1US FAERS
135ApathyFAERS: 1US FAERS
136ArthralgiaFAERS: 1US FAERS
137ArthropathyFAERS: 1US FAERS
138AscitesFAERS: 1US FAERS
139Atrial FibrillationFAERS: 1US FAERS
140Autoimmune hepatitisFAERS: 1US FAERS
141Bipolar I disorderFAERS: 1US FAERS
142Blood alkaline phosphatase increasedFAERS: 1US FAERS
143Blood alkaline phosphatase normalFAERS: 1US FAERS
144Blood chloride increasedFAERS: 1US FAERS
145Blood creatine phosphokinase increasedFAERS: 1US FAERS
146Blood creatinine increasedFAERS: 1US FAERS
147Blood magnesium decreasedFAERS: 1US FAERS
148Blood magnesium increasedFAERS: 1US FAERS
149Blood pH increasedFAERS: 1US FAERS
150Blood potassium decreasedFAERS: 1US FAERS
151Blood sodium increasedFAERS: 1US FAERS
152Blood urea increasedFAERS: 1US FAERS
153Cerebral InfarctionFAERS: 1US FAERS
154Cerebrovascular accidentFAERS: 1US FAERS
155Consciousness fluctuatingFAERS: 1US FAERS
156DeafnessFAERS: 1US FAERS
157DehydrationFAERS: 1US FAERS
158DeliriumFAERS: 1US FAERS
159DementiaFAERS: 1US FAERS
160DermatitisFAERS: 1US FAERS
161DextrocardiaFAERS: 1US FAERS
162Diabetic KetoacidosisFAERS: 1US FAERS
163DiplopiaFAERS: 1US FAERS
164DissociationFAERS: 1US FAERS
165Drug administration errorFAERS: 1US FAERS
166Drug dispensed to wrong patientFAERS: 1US FAERS
167Drug dose omissionFAERS: 1US FAERS
168Drug level below therapeuticFAERS: 1US FAERS
169Dry skinFAERS: 1US FAERS
170DystoniaFAERS: 1US FAERS
171DysuriaFAERS: 1US FAERS
172Ear discomfortFAERS: 1US FAERS
173Echocardiogram abnormalFAERS: 1US FAERS
174Electrocardiogram changeFAERS: 1US FAERS
175Epigastric discomfortFAERS: 1US FAERS
176EpilepsyFAERS: 1US FAERS
177ErythemaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Exposure during breast feedingFAERS: 1US FAERS
179Eye painFAERS: 1US FAERS
180Feeling ColdFAERS: 1US FAERS
181FibromyalgiaFAERS: 1US FAERS
182Foaming at mouthFAERS: 1US FAERS
183Food AllergyFAERS: 1US FAERS
184FormicationFAERS: 1US FAERS
185Gastrointestinal inflammationFAERS: 1US FAERS
186General physical health deteriorationFAERS: 1US FAERS
187GlaucomaFAERS: 1US FAERS
188GlossitisFAERS: 1US FAERS
189Head discomfortFAERS: 1US FAERS
190HemiparesisFAERS: 1US FAERS
191HepatomegalyFAERS: 1US FAERS
192HostilityFAERS: 1US FAERS
193HungerFAERS: 1US FAERS
194HyporeflexiaFAERS: 1US FAERS
195HypoventilationFAERS: 1US FAERS
196Impaired driving abilityFAERS: 1US FAERS
197Impaired gastric emptyingFAERS: 1US FAERS
198Inappropriate affectFAERS: 1US FAERS
199IncoherentFAERS: 1US FAERS
200Incorrect drug dosage form administeredFAERS: 1US FAERS
201Intentional drug misuseFAERS: 1US FAERS
202Intentional product use issueFAERS: 1US FAERS
203Internal injuryFAERS: 1US FAERS
204Joint stiffnessFAERS: 1US FAERS
205LacerationFAERS: 1US FAERS
206Lactose IntoleranceFAERS: 1US FAERS
207LeukocytosisFAERS: 1US FAERS
208Long QT SyndromeFAERS: 1US FAERS
209Loose toothFAERS: 1US FAERS
210LymphadenopathyFAERS: 1US FAERS
211Middle insomniaFAERS: 1US FAERS
212Musculoskeletal stiffnessFAERS: 1US FAERS
213MyocarditisFAERS: 1US FAERS
214NasopharyngitisFAERS: 1US FAERS
215Neck PainFAERS: 1US FAERS
216Negative thoughtsFAERS: 1US FAERS
217Nerve injuryFAERS: 1US FAERS
218NeuralgiaFAERS: 1US FAERS
219NeuropathyFAERS: 1US FAERS
220No adverse eventFAERS: 1US FAERS
221No reaction on previous exposure to drugFAERS: 1US FAERS
222NocturiaFAERS: 1US FAERS
223Oral painFAERS: 1US FAERS
224OsteopeniaFAERS: 1US FAERS
225PallorFAERS: 1US FAERS
226PancreatitisFAERS: 1US FAERS
227Personality ChangeFAERS: 1US FAERS
228PolyuriaFAERS: 1US FAERS
229Poor quality drug administeredFAERS: 1US FAERS
230Post procedural complicationFAERS: 1US FAERS
231Prescribed overdoseFAERS: 1US FAERS
232PresyncopeFAERS: 1US FAERS
233Product packaging issueFAERS: 1US FAERS
234Product physical issueFAERS: 1US FAERS
235Reaction to azo-dyesFAERS: 1US FAERS
236Reaction to excipientFAERS: 1US FAERS
237Renal painFAERS: 1US FAERS
238Respiratory DepressionFAERS: 1US FAERS
239Respiratory FailureFAERS: 1US FAERS
240RetchingFAERS: 1US FAERS
241Sinus bradycardiaFAERS: 1US FAERS
242Skin lesionFAERS: 1US FAERS
243SomnambulismFAERS: 1US FAERS
244SoporFAERS: 1US FAERS
245Supraventricular tachycardiaFAERS: 1US FAERS
246Teeth brittleFAERS: 1US FAERS
247Temperature regulation disorderFAERS: 1US FAERS
248Therapeutic response unexpectedFAERS: 1US FAERS
249Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
250Therapy changeFAERS: 1US FAERS
251ThrombophlebitisFAERS: 1US FAERS
252Tongue discomfortFAERS: 1US FAERS
253Tooth ErosionFAERS: 1US FAERS
254Transcription medication errorFAERS: 1US FAERS
255Trigeminal NeuralgiaFAERS: 1US FAERS
256TrismusFAERS: 1US FAERS
257Urinary tract infectionFAERS: 1US FAERS
258UrticariaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
259Vaginal burning sensationFAERS: 1US FAERS
260VertigoFAERS: 1US FAERS
261Victim of child abuseFAERS: 1US FAERS
262Violence-related symptomFAERS: 1US FAERS
263Visceral congestionFAERS: 1US FAERS
264Visual ImpairmentFAERS: 1US FAERS
265Weight decreasedFAERS: 1US FAERS
266Wheelchair userFAERS: 1US FAERS
267Wrong drug administeredFAERS: 1US FAERS
268furuncleFAERS: 1US FAERS
269nervous system disorderFAERS: 1US FAERS
270Drug level increasedCanada Vigilance: 1Canada Vigilance
271Oculogyric crisisCanada Vigilance: 1Canada Vigilance
272jaundiceCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120330

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.